Michael P. Link
About
Michael P. Link is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Michael P. Link has authored 145 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 48 papers in Public Health, Environmental and Occupational Health and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael P. Link's work include Lymphoma Diagnosis and Treatment (49 papers), Acute Lymphoblastic Leukemia research (45 papers) and Sarcoma Diagnosis and Treatment (39 papers). Michael P. Link is often cited by papers focused on Lymphoma Diagnosis and Treatment (49 papers), Acute Lymphoblastic Leukemia research (45 papers) and Sarcoma Diagnosis and Treatment (39 papers). Michael P. Link collaborates with scholars based in United States, Canada and Germany. Michael P. Link's co-authors include Sarah S. Donaldson, Allen M. Goorin, Jonathan J. Shuster, Holcombe E. Grier, Mark C. Gebhardt, Teresa J. Vietti, Alberto G. Ayala, Paul A. Meyers, Nancy J. Tarbell and Mark Krailo and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.
In The Last Decade
Michael P. Link
144 papers receiving 9.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Michael P. Link United States | 55 | 4.5k | 2.5k | 2.5k | 2.0k | 1.6k | 145 | 9.9k | ||
| William M. Crist United States | 44 | 4.9k 1.1× | 2.6k 1.0× | 2.6k 1.0× | 1.9k 0.9× | 1.6k 1.0× | 145 | 9.5k | ||
| Holcombe E. Grier United States | 57 | 5.7k 1.3× | 1.8k 0.7× | 2.4k 0.9× | 2.5k 1.2× | 2.0k 1.3× | 145 | 11.7k | ||
| Charles B. Pratt United States | 50 | 3.7k 0.8× | 1.4k 0.6× | 2.8k 1.1× | 1.2k 0.6× | 1.7k 1.1× | 198 | 8.5k | ||
| Jeremy Whelan United Kingdom | 48 | 5.2k 1.2× | 1.8k 0.7× | 3.4k 1.4× | 980 0.5× | 1.4k 0.9× | 194 | 9.6k | ||
| Carlos Rodríguez‐Galindo United States | 63 | 3.7k 0.8× | 1.6k 0.7× | 4.1k 1.6× | 1.4k 0.7× | 3.5k 2.2× | 356 | 13.7k | ||
| Norman Jaffe United States | 54 | 4.4k 1.0× | 1.1k 0.4× | 2.5k 1.0× | 1.0k 0.5× | 1.9k 1.2× | 201 | 9.8k | ||
| Heribert Jürgens Germany | 48 | 7.5k 1.7× | 1.6k 0.6× | 3.2k 1.3× | 725 0.4× | 2.3k 1.5× | 186 | 11.9k | ||
| Thierry Philip France | 52 | 3.3k 0.7× | 4.6k 1.8× | 4.8k 1.9× | 1.3k 0.6× | 999 0.6× | 277 | 12.0k | ||
| Paul A. Meyers United States | 66 | 9.0k 2.0× | 2.1k 0.8× | 4.2k 1.7× | 756 0.4× | 2.3k 1.5× | 262 | 15.7k | ||
| Rochelle E. Curtis United States | 53 | 2.2k 0.5× | 2.7k 1.1× | 4.3k 1.7× | 1.6k 0.8× | 1.7k 1.1× | 109 | 11.2k |
Countries citing papers authored by Michael P. Link
Since
Specialization
Citations
This map shows the geographic impact of Michael P. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Link more than expected).
Fields of papers citing papers by Michael P. Link
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michael P. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Link. The network helps show where Michael P. Link may publish in the future.
Co-authorship network of co-authors of Michael P. Link
This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Link. A scholar is included among the top collaborators of Michael P. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Link. Michael P. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Link, Michael P., et al.. (2025). Potential Region-Specific Neuroprotective Effects of Kynurenine Administration in Healthy Rodents Using High-Resolution Mass Spectrometry. ACS Chemical Neuroscience. 16(19). 3682–3693.
2.
Chen, Yan, Yutaka Yasui, Rachel Phelan, et al.. (2024). Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Pediatric Blood & Cancer. 71(10). e31189–e31189.
3.
Theruvath, Ashok J., Florian Siedek, Anne M. Muehe, et al.. (2020). Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI. Radiology. 296(1). 143–151.
4.
Uslu, Lebriz, Jessica Donig, Michael P. Link, et al.. (2015). Value of18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies. Journal of Nuclear Medicine. 56(2). 274–286.
5.
Ozawa, Michael G., Martina I. Lefterova, Sandra Luna‐Fineman, et al.. (2015). The utility of IgM, CD21, HGAL and LMO2 in the diagnosis of pediatric follicular lymphoma. Human Pathology. 46(4). 629–633.
6.
Thakral, Charu, R. Hutchison, Antony E. Shrimpton, et al.. (2012). ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol‐3 kinase/akt activity with retained but inactivated PTEN—A report from the Children's Oncology Group. Pediatric Blood & Cancer. 59(3). 440–447.
7.
Meyers, Paul A., Cindy L. Schwartz, Mark Krailo, et al.. (2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(4). 633–638.
8.
Hutchison, R., Joseph Laver, Myron Chang, et al.. (2008). Non‐anaplastic peripheral t‐cell lymphoma in childhood and adolescence: A Children's Oncology Group study. Pediatric Blood & Cancer. 51(1). 29–33.
9.
Donaldson, Sarah S., Michael P. Link, Howard J. Weinstein, et al.. (2007). Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease. Journal of Clinical Oncology. 25(3). 332–337.
10.
Perheentupa, Jaakko, et al.. (2007). Testis-expressed protein TSGA10 - an auto-antigen in autoimmune polyendocrine syndrome type I. International Immunology. 20(1). 39–44.
11.
Miser, James S., Mark Krailo, Nancy J. Tarbell, et al.. (2004). Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group Study. Journal of Clinical Oncology. 22(14). 2873–2876.
12.
Baker, K. Scott, James R. Anderson, Thom E. Lobe, et al.. (2002). Children From Ethnic Minorities Have Benefited Equally as Other Children From Contemporary Therapy for Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group. Journal of Clinical Oncology. 20(22). 4428–4433.
13.
Ferguson, William S., Michael B. Harris, Allen M. Goorin, et al.. (2001). Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial. The American journal of pediatric hematology/oncology. 23(6). 340–348.
14.
Breneman, John C., J R Anderson, Sarah S. Donaldson, et al.. (2001). Prognostic factors and outcome in children with metastatic rhabdomyosarcoma - a report from the intergroup rhabdomyosarcoma study IV. International Journal of Radiation Oncology*Biology*Physics. 51(3). 118–118.
15.
Harris, Michael B., Peter W. Gieser, Allen M. Goorin, et al.. (1998). Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.. Journal of Clinical Oncology. 16(11). 3641–3648.
16.
Crist, W M, J J Shuster, Thomas Look, et al.. (1992). Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia. 6. 162–165.
17.
Vats, Tribhawan S., George R. Buchanan, Paulette Mehta, et al.. (1992). A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. Investigational New Drugs. 10(3). 231–234.
18.
Niethammer, D., T. Klingebiel, R. Dopfer, et al.. (1990). Allogeneic Bone Marrow Transplantation in Childhood Leukemia: Results and Strategies in the Federal Republic of Germany. Hämatologie und Bluttransfusion. 33. 638–648.
19.
Link, Michael P., Sarah S. Donaldson, Costan W. Berard, Jonathan J. Shuster, & Sharon B. Murphy. (1990). Results of Treatment of Childhood Localized Non-Hodgkin's Lymphoma with Combination Chemotherapy with or without Radiotherapy. New England Journal of Medicine. 322(17). 1169–1174.
20.
Wright, Ann, Michael P. Link, SD Smith, et al.. (1989). Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.. The Journal of Experimental Medicine. 169(5). 1557–1564.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by William M. Crist Breakdown of academic impact, for papers by Holcombe E. Grier Breakdown of academic impact, for papers by Charles B. Pratt Breakdown of academic impact, for papers by Jeremy Whelan Breakdown of academic impact, for papers by Carlos Rodríguez‐Galindo Breakdown of academic impact, for papers by Norman Jaffe Breakdown of academic impact, for papers by Heribert Jürgens Breakdown of academic impact, for papers by Thierry Philip Breakdown of academic impact, for papers by Paul A. Meyers Breakdown of academic impact, for papers by Rochelle E. Curtis